Islet secretion of immunoreactive thyrotropin-releasing hormone and the 'paracrine-like' effects of its exogenous administration

• Published in: Acta endocrinologica (Copenhagen) Vol. 118; no. 3; pp. 429 - 436
• Main Authors: Vara, E, Tamarit-Rodríguez, J
• Format: Journal Article
• Language: English
• Published: Denmark 01.07.1988
• Subjects: Animals; Glucagon - metabolism; Glucose Tolerance Test; Insulin - metabolism; Insulin Secretion; Islets of Langerhans - metabolism; Male; Palmitic Acid; Palmitic Acids - pharmacology; Rats; Rats, Inbred Strains; Somatostatin - metabolism; Thyrotropin-Releasing Hormone - administration & dosage; Thyrotropin-Releasing Hormone - immunology; Thyrotropin-Releasing Hormone - metabolism
• ISSN: 0804-4643; 0001-5598; 1479-683X
• DOI: 10.1530/acta.0.1180429

In order to know more about the secretory pattern of islet TRH in response to glucose and its possible physiological relevance, the release of this hormone as well as that of insulin, glucagon, and somatostatin was radioimmunologically measured. Whereas the secretion of immunoreactive insulin and somatostatin by incubated rat islets is known to be dose-dependently stimulated by glucose, that of glucagon and TRH was inhibited by glucose. Similarly, palmitate dose-dependently inhibited islet glucagon and TRH release. Exogenous TRH exerted strong and dose-dependent effects on islet secretion of the other hormones at the same concentration range at which its hypophysiotropic effects are produced (10−10 to 10−8 mol/l). It inhibited the insulin response to glucose and blocked that of glucagon, whereas it enhanced glucose-induced stimulation of somatostatin. These results are suggestive of a possible paracrine inhibitory role of islet TRH, either directly exerted on the secretion of insulin and glucagon or partially mediated through the stimulation of somatostatin release.